An assay of CF transmembrane conductance regulator function that uses primary CF intestinal organoids: shared experiences with the Russian CF centre

J. Beekman (Utrecht, Netherlands)

Source: International Congress 2018 – Russian Speaking Programme 2018: Part I
Session: Russian Speaking Programme 2018: Part I
Session type: Language session
Number: 6

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Beekman (Utrecht, Netherlands). An assay of CF transmembrane conductance regulator function that uses primary CF intestinal organoids: shared experiences with the Russian CF centre. International Congress 2018 – Russian Speaking Programme 2018: Part I

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A three miRNA signature regulates the CF transmembrane conductance regulator (CFTR) in cystic fibrosis airway epithelium
Source: Annual Congress 2011 - Epithelial cells: role in health and disease
Year: 2011

How organoids helped to discover cystic fibrosis transmembrane conductance regulator (CFTR) therapeutics and predict response to treatment
Source: International Congress 2016 – Closing the gap: novel translational research strategies
Year: 2016


The cystic fibrosis transmembrane conductance regulator: state of the art
Source: Breathe 2008; 5: 163-167
Year: 2008

Measuring CFTR function in respiratory epithelial cell cultures: step to individualize treatments in cystic fibrosis?
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021

Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells
Source: Eur Respir J 2015; 45: 1590-1602
Year: 2015



Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient
Source: Eur Respir J 2002; 19: 374-376
Year: 2002



Cystic fibrosis transmembrane conductance regulator pharmacotherapy
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88
Year: 2006

The cystic fibrosis transmembrane conductance regulator and its modulators: clinical implications
Source: Virtual Congress 2020 – Respiratory infections
Year: 2020


Association of residual function of cystic fibrosis transmembrane conductance regulator and lung clearance index in patients with normal FEV1
Source: International Congress 2017 – Assessing the impact of respiratory and sleep problems in children
Year: 2017

CFTR biomarkers: time for promotion to surrogate end-point
Source: Eur Respir J 2013; 41: 203-216
Year: 2013



Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis
Source: Eur Respir Rev 2013; 22: 58-65
Year: 2013



Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target
Source: ERJ Open Res, 7 (4) 00247-2021; 10.1183/23120541.00247-2021
Year: 2021



Allosteric inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) slows airway mucus transport in normal sheep
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function
Source: Eur Respir J 2011; 37: 1076-1082
Year: 2011



CF centre care-adults
Source: ERS course 2015
Year: 2015


CF centre care-paediatrics
Source: ERS course 2015
Year: 2015


Atypical cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38
Year: 2006

Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator (CFTR) ion transport
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013

Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
Source: Breathe, 17 (3) 210088; 10.1183/20734735.0088-2021
Year: 2021



Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019
Year: 2021